High Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Recurrent Coronary Events in Postinfarction Patients
Open Access
- 1 July 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (7) , 1331-1338
- https://doi.org/10.1373/clinchem.2006.066845
Abstract
Background: Recent studies demonstrate that lipoprotein-associated phospholipase A2 (Lp-PLA2) is a risk factor for cardiovascular disease presumably deriving from generation of proinflammatory and proatherogenic species through its hydrolytic activity on lipoprotein-associated phospholipids. The goal of this study was to assess the relationship of Lp-PLA2 with a set of thrombogenic, lipid, inflammatory, and metabolic blood markers and to determine whether plasma Lp-PLA2 is a risk factor for recurrent coronary events in postinfarction patients.Keywords
This publication has 20 references indexed in Scilit:
- Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patientsAtherosclerosis, 2005
- Role of Lipoprotein-Associated Phospholipase A 2 in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic StrokeCirculation, 2005
- Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndromeAtherosclerosis, 2004
- Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-upEuropean Heart Journal, 2004
- Lipoprotein-Associated Phospholipase A 2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General PopulationCirculation, 2004
- Lipoprotein-Associated Phospholipase A 2 , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) StudyCirculation, 2004
- Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patientsAtherosclerosis, 2003
- Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular diseaseCurrent Opinion in Lipidology, 2003
- Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart DiseaseNew England Journal of Medicine, 2000